Drawing for BIOTRAD

USPTO serial 85710637

BIOTRAD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ROSSMAN, MARY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOTRAD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Hanes

CHRISTOPHER M. HANES GlaxoSmithKlineFive Moore DriveLegal Global Trademarks, Mailstop: 5.5AResearch Triangle Park, NC 27709-0183

Goods and services

ClassDescriptionStatusFirst use
005(Based on 44(e)) (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; VaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 18, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 18, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 6, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 5, 2015EX5GSOU EXTENSION 5 GRANTED—
Jul 29, 2015EXT5SOU EXTENSION 5 FILED—
Jul 29, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 18, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 17, 2015EX4GSOU EXTENSION 4 GRANTED—
Mar 2, 2015EXT4SOU EXTENSION 4 FILED—
Mar 2, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2014EX3GSOU EXTENSION 3 GRANTED—
Aug 28, 2014EXT3SOU EXTENSION 3 FILED—
Aug 28, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 3, 2014EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 2, 2014EX2GSOU EXTENSION 2 GRANTED—
Mar 28, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 3, 2014EXT2SOU EXTENSION 2 FILED—
Mar 3, 2014EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 6, 2013EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 4, 2013EX1GSOU EXTENSION 1 GRANTED—
Sep 4, 2013EXT1SOU EXTENSION 1 FILED—
Sep 4, 2013EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 20, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 20, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 12, 2013NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 15, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 15, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 26, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 7, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 4, 2012DOCKASSIGNED TO EXAMINER—
Aug 31, 2012MPMKNOTICE OF PSEUDO MARK MAILED—
Aug 30, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 25, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance